Karuna Therapeutics to Announce Third Quarter 2023 Financial Results and Provide General Business Update on Thursday, November 2, 2023
Rhea-AI Summary
Karuna Therapeutics to host conference call and webcast to review Q3 2023 financial results
10/19/2023 - 06:30 AM
BOSTON --(BUSINESS WIRE)--
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that it will host a live conference call and webcast on Thursday, November 2, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and provide a general business update.
A live webcast of the presentation will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com . A replay of the webcast will also be archived for up to 30 days on Karuna’s website following the completion of the event.
About Karuna Therapeutics
Karuna Therapeutics is a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by serious mental illness. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20231019342719/en/
Investors:
asmith@karunatx.com
Media:
julie.ciardiello@karunatx.com
Source: Karuna Therapeutics, Inc.
When will Karuna Therapeutics host the conference call and webcast?
Karuna Therapeutics will host the conference call and webcast on Thursday, November 2, 2023 at 8:00 a.m. ET.
What will be discussed during the conference call and webcast?
During the conference call and webcast, Karuna Therapeutics will review their third quarter 2023 financial results and provide a general business update.
Where can I access the live webcast of the presentation?
The live webcast of the presentation will be available on the Investor Relations page of Karuna's website at investors.karunatx.com.
Will there be a replay of the webcast available?
Yes, a replay of the webcast will be archived for up to 30 days on Karuna's website following the completion of the event.
KRTX Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major, Manufacturing, Pharmaceutical Preparation Manufacturing
About KRTX
we are an innovative clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical need. our pipeline is built on the broad therapeutic potential of our lead product candidate, karxt, an oral modulator of muscarinic receptors that are located both in the central nervous system, or cns, and various peripheral tissues. karxt is our proprietary product candidate that combines xanomeline, a novel muscarinic agonist, with trospium, an approved muscarinic antagonist, to preferentially stimulate muscarinic receptors in the cns. we have assembled a team with extensive expertise in the research, development and commercialization of numerous cns agents, as well as deep familiarity with the biology of neuropsychiatric disorders, such as schizophrenia and ad, including the role of muscarinic receptors in their potential treatment. we will leverage this expertise to develop a pip
